国庆
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
luoking
Lv1
90 积分
2026-04-08 加入
最近求助
最近应助
互助留言
DOACs: role of anti-Xa and drug level monitoring
41分钟前
求助中
20 years of progress in the classification of immune-mediated diseases
1个月前
已完结
Integrating human and artificial intelligence for robust postmarketing safety surveillance systems: reflections from the FDA Sentinel Innovation Center
2个月前
已完结
MEVPRO-3: Phase III trial of mevrometostat plus enzalutamide (versus placebo plus enzalutamide) in metastatic castration-sensitive prostate cancer (mCSPC)
2个月前
已采纳
Changes in CTCAE v6: Effect on dose-escalation and dose-limiting toxicity with repeat analysis of recent clinical trials
2个月前
已采纳
感谢
1个月前
感谢，速度真快，帮大忙了
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论
DOACs: role of anti-Xa and drug level monitoring
20 years of progress in the classification of immune-mediated diseases
Integrating human and artificial intelligence for robust postmarketing safety surveillance systems: reflections from the FDA Sentinel Innovation Center
MEVPRO-3: Phase III trial of mevrometostat plus enzalutamide (versus placebo plus enzalutamide) in metastatic castration-sensitive prostate cancer (mCSPC)
皖公网安备34019202002308
